← Back to news

Markets

Gold Fails to Capitalize on Safe-Haven Demand After Iran Strikes

Y

Is Skyworks Solutions Stock Underperforming the Dow?

Y

Is Bunge Global Stock Underperforming the S&P 500?

Y

U.S. Natural Gas Futures Start Week Lower

Y

How Is AES Corporation's Stock Performance Compared to Other Utilities Stocks?

Y

Global Markets Relatively Muted; Oil Price Rises on Escalating Middle East Conflict

Y

The Iran-Israel conflict isn't denting Chinese business optimism in the Middle East

F

Oil Stays Volatile as Markets Weigh U.S. Attacks on Iran

Y

Oil Volatility Remains High After U.S. Struck Iran’s Nuclear Sites

Y

KB Home Earnings Beat Wall Street Forecast. The Stock Is Falling Because of Guidance.

Y

U.S. Home Sales Likely Fell Last Month

Y

Market Impacts Of U.S.-Iran Escalation

S

Heard on the Street Friday Recap: Home Cooking

Y

Prosus bets on tech investment, beats target with core earnings up 47%

Y

Tencent Shareholder Prosus Logs Higher Revenue, Earnings on Strong E-Commerce Growth

Y

Stellantis' new CEO makes small changes to management, shares fall

Y

The Bond Market’s Biggest Risk Isn’t the Deficit, Economist Says. Here’s What Is.

Y

SA Quant Top 10: A Stellar Mid-Year Result

S

Analysts react as markets brace for Iran response to US attack

Y

Zhejiang Sanhua Stumbles in Hong Kong Debut

Y

Intellia Reports Positive 3-Year Lonvo-z Data in HAE Trial at EAACI Congress

Y

Omega Healthcare Investors: Growing And Paying A Healthy Yield

S

Twist and Element Biosciences Expands Pact for Sequencing Workflow Solutions

Y

Lilly To Acquire Verve For One-Time Cardiovascular Treatments

Y

10x Genomics Settles Patent Dispute With Bruker

Y

Lake Street: AMT-130 Could Be Game-Changer For ClearPoint

Y

Barclays Initiates BioMarin Pharmaceutical Inc. (BMRN) with a Buy Rating

Y

Exact Sciences Expands Oncodetect Validation, Unveils MRD Innovation Roadmap.

Y

First Patient Dosed In Phase 3 REVEAL Study Of ION582 For Angelman Syndrome

Y

Canaccord Raises Price Target Of Illumina, Inc. (ILMN).

Y

UBS Lowers Price Target On Regeneron Pharmaceuticals, Inc. (REGN).

Y

The Market Faces a Slew of July Risks. It’s a Test for S&P 500 Rally.

Y

Cement maker Holcim completes $30 billion North American spin-off

Y

Chop Tape Sets The Market Up For Higher (Technical Analysis)

S

U.S. Strikes On Iran Intensify Oil Supply Risks

S

York Water: Significant Upside Potential, Limited Downside Risk

S

AGNC: Lock-In High Dividend And Build A Good Income Stream

S

‘Uncertain’ 2025, M&A Deadlock Freeze $1 Trillion in PE Assets

Y

Cybersecurity Giant Palo Alto Networks Caught Between Opportunity and Maturity

Y

South Korea industry ministry flags concerns over US strike on Iran

Y

Chinese Stocks and American Exchanges Head for a Breakup

Y

Wolfspeed plans US bankruptcy filing in deal reached with creditors

Y

Dollar falls on dovish Fed comments

Y

Update: oil prices fall back after short-lived surge in early trading

Y

Dow futures drop 150 points while oil prices jump after the U.S. bombs Iran’s nuclear sites and widens Mideast conflict

Y

Millions of Résumés Never Make It Past the Bots. One Man Is Trying to Find Out Why.

Y